NCT02622191

Brief Summary

The study aims to further understand glaucoma pathogenesis and progression by utilizing enhanced depth imaging optical coherence tomography to visualize and measure lamina cribrosa in vivo and segmentation technology to accurately delineate and measure boundaries of the retinal layers. Investigators will elaborate further on key concepts of lamina cribrosa thickness and trans-synaptic degeneration.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2012

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

November 17, 2015

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 4, 2015

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

February 27, 2019

Completed
Last Updated

March 15, 2019

Status Verified

February 1, 2019

Enrollment Period

3 months

First QC Date

November 17, 2015

Results QC Date

December 13, 2017

Last Update Submit

February 27, 2019

Conditions

Keywords

GlaucomaOptical Coherence TomographyPrimary Open Angle GlaucomaVisual Field

Outcome Measures

Primary Outcomes (1)

  • Lamina Cribrosa (Boundaries of the Retinal Layers) Measurements

    Using Spectral Domain optical coherence tomography (SD-OCT), horizontal macular thickness of the lamina cribrosa (boundaries of the retinal layers) is measured in the eyes of each participant in microohms.

    1 examination, approximately one hour

Study Arms (2)

Open-angle glaucoma

EXPERIMENTAL

Participants with primary open-angle glaucoma and an abnormal visual field defect in one eye. Spectral domain Optical Coherence Tomography will be obtained from the effected eye and fellow eye of each glaucoma patient.

Device: Spectral domain Optical Coherence Tomography

Healthy Controls

EXPERIMENTAL

Participants without glaucoma and no other eye diseases. Spectral domain Optical Coherence Tomography will be obtained from eyes of each healthy control.

Device: Spectral domain Optical Coherence Tomography

Interventions

Undilated peripapillary circular optic nerve scans and horizontal and vertical SD-OCT B-scan images centered on the fovea were acquired using Spectralis Heidelberg Retinal Angiography (HRA)+OCT (Heidelberg Engineering GmbH, Heidelberg, Germany).

Also known as: SD-OCT
Healthy ControlsOpen-angle glaucoma

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Best-corrected visual acuity of 20/40 or better
  • No media opacities
  • Spherical equivalent refractive errors in a range of -6 to +6 diopters
  • Cylinder correction within 3.0 diopters.

You may not qualify if:

  • Age \< 18 years old
  • Visual Acuity \< 20/40
  • Nuclear sclerosis \> +2
  • Corneal diseases
  • Contact lens use
  • History of posterior segment intraocular surgery
  • Systemic or ocular diseases that can cause visual field loss.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Zangalli CS, Ahmed OM, Waisbourd M, H Ali M, Cvintal V, Affel E, Gupta L, Katz LJ, C Sergott R. Segmental Analysis of Macular Layers in Patients With Unilateral Primary Open-Angle Glaucoma. J Glaucoma. 2016 Apr;25(4):e401-7. doi: 10.1097/IJG.0000000000000336.

MeSH Terms

Conditions

GlaucomaGlaucoma, Open-Angle

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Limitations and Caveats

Manual segmentation of macular layers, somewhat subjective measure, prone to errors of interpretation. Cross sectional design did not allow for longitudinal tracking of fellow eyes. Pilot study was restricted by small sample size.

Results Point of Contact

Title
Dr. L. Jay Katz
Organization
Wills Eye Hospital, Glaucoma Research Center

Study Officials

  • L J Katz, MD

    Wills Eye Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 17, 2015

First Posted

December 4, 2015

Study Start

November 1, 2012

Primary Completion

February 1, 2013

Study Completion

December 1, 2013

Last Updated

March 15, 2019

Results First Posted

February 27, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share